Acral necrosis
| Acral Necrosis | |
|---|---|
| Acral necrosis due to bubonic plague.jpg | |
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Black discoloration of fingers, toes, ears, nose |
| Complications | Infection, gangrene, amputation |
| Onset | N/A |
| Duration | N/A |
| Types | N/A |
| Causes | Vascular occlusion, sepsis, frostbite, Raynaud's phenomenon |
| Risks | N/A |
| Diagnosis | Clinical examination, Doppler ultrasound, angiography |
| Differential diagnosis | N/A |
| Prevention | N/A |
| Treatment | Revascularization, antibiotics, debridement, amputation |
| Medication | N/A |
| Prognosis | Variable, depending on underlying cause |
| Frequency | Rare |
| Deaths | N/A |


Acral necrosis is a medical condition characterized by the death of tissue in the extremities, such as the fingers, toes, ears, and nose. This condition is often a result of inadequate blood supply, leading to tissue ischemia and necrosis.
Etiology[edit]
Acral necrosis can be caused by a variety of factors, including:
- Vascular occlusion: This can occur due to thrombosis, embolism, or vasculitis.
- Sepsis: Severe infections can lead to disseminated intravascular coagulation (DIC), which can cause microvascular occlusion.
- Frostbite: Exposure to extreme cold can lead to freezing of tissues and subsequent necrosis.
- Raynaud's phenomenon: This condition causes episodic vasospasm of the arteries, leading to reduced blood flow.
- Diabetes mellitus: Poorly controlled diabetes can lead to peripheral vascular disease and neuropathy, increasing the risk of necrosis.
Pathophysiology[edit]
The pathophysiology of acral necrosis involves the interruption of blood flow to the affected areas, leading to tissue ischemia. Without adequate oxygen and nutrient supply, the tissue undergoes necrosis. The necrotic tissue can become a site for bacterial infection, further complicating the condition.
Clinical Presentation[edit]
Patients with acral necrosis typically present with:
- Black discoloration: The affected areas may appear black or dark brown due to tissue death.
- Pain: Initially, there may be pain due to ischemia, but as necrosis progresses, the area may become numb.
- Swelling: Inflammation may occur around the necrotic tissue.
- Ulceration: Open sores may develop as the necrotic tissue breaks down.
Diagnosis[edit]
Diagnosis of acral necrosis involves:
- Clinical examination: Physical examination of the affected areas.
- Doppler ultrasound: To assess blood flow in the affected extremities.
- Angiography: Imaging to visualize blood vessels and identify occlusions.
- Blood tests: To check for underlying conditions such as diabetes or infection.
Treatment[edit]
The treatment of acral necrosis depends on the underlying cause and may include:
- Revascularization: Surgical procedures to restore blood flow, such as bypass surgery or angioplasty.
- Antibiotics: To treat or prevent infection in necrotic tissue.
- Debridement: Surgical removal of necrotic tissue to promote healing.
- Amputation: In severe cases, removal of the affected extremity may be necessary.
Prognosis[edit]
The prognosis of acral necrosis varies depending on the underlying cause and the timeliness of treatment. Early intervention can improve outcomes, but severe cases may result in permanent loss of function or amputation.
Prevention[edit]
Preventive measures include:
- Managing underlying conditions: Such as diabetes and vascular diseases.
- Avoiding exposure to extreme cold: To prevent frostbite.
- Regular medical check-ups: For early detection and management of risk factors.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
